Dawood v. Gamer Advantage LLC

• Court: District Court, E.D. California
• Decided: August 4, 2022
• Docket: 2:22-cv-00562
• Status: Unknown

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 EASTERN DISTRICT OF CALIFORNIA 10 ----oo0oo---- 11 12 MAHMOOD DAWOOD, on behalf of No. 2:22-cv-00562 WBS KJN himself and all others similarly 13 situated, 14 Plaintiff, MEMORANDUM AND ORDER RE: DEFENDANT’S MOTION TO DISMISS 15 v. 16 GAMER ADVANTAGE LLC, 17 Defendant. 18 19 ----oo0oo---- 20 Plaintiff Mahmood Dawood brought this putative class 21 action against defendant Gamer Advantage LLC alleging fifteen 22 claims in connection with defendant’s FogAway Anti-Fog Spray 23 (“FogAway”). (Docket No. 1.) Defendant moves to dismiss 24 plaintiff’s complaint for failure to state a claim pursuant to 25 Federal Rule of Civil Procedure 12(b)(6). (Docket No. 7.) 26 I. Factual and Procedural Background 27 Defendant formulates, designs, manufactures, 28 advertises, distributes, and sells FogAway across the United 1 States, including in California. (Compl. ¶ 1.) FogAway is 2 supposed to prevent foggy eyeglasses, which have become a more 3 common problem because of the use of face masks during the COVID- 4 19 pandemic. (Id. ¶ 14.) 5 In approximately the summer of 2021, plaintiff 6 purchased FogAway from a Walmart retail store in Lodi, 7 California. (Id. ¶ 9.) Before purchasing FogAway, plaintiff 8 “reviewed the labeling, packaging, and marketing materials” and 9 saw the claims that FogAway is “Safe For Use.”1 (Id.) Plaintiff 10 understood this to be a representation and warranty by defendant 11 that FogAway is “in fact safe for use.” (Id.) 12 The complaint alleges that FogAway contains unsafe per- 13 and polyfluoroalkyl substances (“PFAS”) which “have been shown to 14 have a number of toxicological effects” and exposure can lead to 15 “cancer, liver damage, decreased fertility, and increased risk of 16 asthma and thyroid disease.” (Id. ¶¶ 2-3.) Based on a study 17 done by the Nicholas School of Environment at Duke University, 18 FogAway allegedly exposes consumers to PFAS at levels higher than 19 the Environmental Protection Agency health advisory limit for 20 safe consumption and contains more PFAS than its competitors. 21 (Id. ¶¶ 4-6, 22.) 22 Defendant allegedly concealed the existence of PFAS in 23 FogAway. (Id. ¶ 40.) Plaintiff claims that if he had known 24 about the PFAS, he would not have purchased, or would not have 25

26 1 The court notes that “Safe For Use” is not the complete statement on the advertising and labeling for FogAway, as shown 27 in the photos submitted by plaintiff in his complaint. (Compl. ¶ 19.) The implication of this difference as it relates to 28 defendant’s motion to dismiss is discussed below. 1 purchased on the same terms, FogAway. (Id. ¶ 9.) 2 Plaintiff alleges the following claims against 3 defendant: (1) violation of California’s Unfair Competition Law 4 (“UCL”), Cal. Bus. & Prof. Code § 17200; (2) violation of 5 California’s Consumers Legal Remedies Act (“CLRA”), Cal. Civ. 6 Code § 1750; (3) breach of the implied warranty under the Song- 7 Beverly Act, Cal. Civ. Code § 1790; (4) violation of California’s 8 False Advertising Law, Cal. Bus. & Prof. Code § 17500; (5) fraud; 9 (6) constructive fraud; (7) fraudulent inducement; (8) money had 10 and received; (9) fraudulent concealment or omission; (10) 11 fraudulent misrepresentation; (11) negligent misrepresentation; 12 (12) quasi-contract/unjust enrichment; (13) breach of express 13 warranty; (14) violation of the Magnuson-Moss Warranty Act, 15 14 U.S.C. §§ 2301, et seq.; and (15) negligent failure to warn. 15 (See Compl.) 16 II. Discussion 17 In his opposition, plaintiff conceded his claims for 18 money had and received and negligent failure to warn. (Pl.’s 19 Opp’n at 23 n.4 (Docket No. 9).) Accordingly, these claims will 20 be dismissed. 21 For the remaining claims, defendant argues that 22 plaintiff’s complaint should be dismissed in its entirety 23 because: (1) the representations made by defendant about FogAway 24 are different from those the complaint alleges; (2) the complaint 25 fails to allege a causal relationship between the cost-of- 26 purchase damages and the alleged health-related dangers of 27 FogAway; (3) the class claims rely on conclusory allegations; and 28 (4) the allegations for the fraud-based claims do not satisfy 1 Federal Rule of Civil Procedure 9(b) (“Rule 9(b)”). (Def.’s Mot. 2 at 2.) The court analyzes each argument below. 3 A. Representations about FogAway 4 The complaint alleges that the advertisements and 5 labeling of FogAway represent the product is “Safe For Use.” 6 (Compl. ¶ 9.) However, plaintiff also submits screenshots and 7 photographs of the following actual representations on the 8 advertisements and labeling, which are: (1) “Safe to apply on all 9 lenses, devices, & screens;” (2) “Safe for use on all lenses and 10 devices;” and (3) “Safe and effective on all lens types even 11 those with anti-reflective or super hydrophobic coating.” (Id. ¶ 12 19.) 13 “Dismissal is appropriate only in the ‘rare situation’ 14 where the ‘advertisement itself made it impossible for the 15 plaintiff to prove that a reasonable consumer was likely to be 16 deceived.’” Morales v. Unilver U.S., Inc., No. 2:13-cv-2213-WBS, 17 2014 WL 1389613, at *6 (E.D. Cal. Apr. 9, 2014) (quoting Williams 18 v. Gerber Prods. Co., 552 F.3d 934, 939 (9th Cir. 2008)). This 19 is not that rare situation. 20 How consumers would interpret these representations is 21 a question of fact, and not a question that the court can resolve 22 at this stage. See Zeiger v. WellPet LLC, 304 F. Supp. 3d 837, 23 852 (N.D. Cal. 2018) (“Plaintiffs have provided an actionable 24 theory why the Products are unsafe and why the labels are 25 misleading; whether plaintiffs can prove their theory is a 26 separate question that I cannot resolve at [the motion to 27 dismiss] stage.”) Accepting the allegations in the complaint as 28 true, the complaint sufficiently alleges that consumers could 1 interpret, and that plaintiff did interpret, these 2 representations to mean that the product was safe for use as it 3 relates to human exposure. (See Compl. ¶ 20); Ashcroft v. Iqbal, 4 556 U.S. 662, 678 (2009). Further, plaintiff’s claims are also 5 based upon defendant’s omissions regarding the existence of PFAS 6 in FogAway, and therefore, consumers could interpret FogAway to 7 be safe because of defendant’s omissions regardless of whether 8 defendant explicitly stated FogAway is safe. (See, e.g., Compl. 9 ¶¶ 9, 39, 41-42, 44-45.) Accordingly, the complaint will not be 10 dismissed based on this argument. 11 B. Damages 12 Defendant argues that the complaint does not allege any 13 “physical harm” or “safety-related damages . . . as a result of” 14 plaintiff purchasing FogAway based on the alleged 15 misrepresentations and/or omissions. (Def.’s Mot. at 5-6.) 16 Plaintiff’s alleged injury is that he “purchased, paid a premium, 17 or otherwise paid more for [FogAway] when [he] otherwise would 18 not have absent [d]efendant’s misrepresentations and/or 19 omissions” –- a purely economic injury. (Compl. ¶ 45.) The 20 complaint also alleges in conclusory terms that the defendant 21 “caused injuries and other damages” but does not provide any 22 supporting factual allegations. (See id. ¶¶ 124, 145, 182, 213.) 23 Pursuant to the economic loss doctrine, “[i]n actions 24 for negligence, a manufacturer’s liability is limited to damages 25 for physical injuries; no recovery is allowed for economic loss 26 alone.” Aas v. Superior Ct., 24 Cal. 4th 627, 724 (2000), 27 superseded by statute on other grounds, Cal. Civ. Code §§ 895– 28 945.5. However, the economic loss doctrine does not bar fraud 1 and intentional misrepresentation claims when they are 2 independent of a breach of contract, and “limited to a 3 defendant’s affirmative misrepresentations on which a plaintiff 4 relies and which expose plaintiff to liability for personal 5 damages independent of the plaintiff’s economic loss.” See 6 Robinson Helicopter Co., Inc. v. Dana Corp., 34 Cal. 4th 979, 7 991, 993 (2004). 8 Neither the Ninth Circuit, in any published opinion, 9 nor the California Supreme Court has analyzed how and if the 10 economic loss doctrine applies to claims for negligent 11 misrepresentation, which “occupy the space between negligence and 12 fraud claims.” See Bret Harte Union High School Dist. v. 13 FieldTurf, USA, Inc., No. 1:16-cv-00371-DAD, 2016 WL 3519294, at 14 *5 (E.D. Cal. June 17, 2016). Two unpublished Ninth Circuit 15 cases have suggested that negligent misrepresentation claims are 16 not barred by the economic loss doctrine. See Hannibal Pictures, 17 Inc. v. Sonja Prods. LLC, 432 F. App’x 700, 701 (9th Cir. 2011) 18 (holding that a jury verdict in favor of a negligent 19 misrepresentation claim was not barred by the economic loss 20 doctrine); Kalitta Air, L.L.C. v. Cent. Tex. Airborne Sys., Inc., 21 315 F. App’x 603, 607 (9th Cir. 2008) (“California law classifies 22 negligent misrepresentation as a species of fraud . . . for which 23 economic loss is recoverable.”) 24 District courts in California have seemingly reached 25 opposing conclusions on this issue. See, e.g, Bret Harte, 2016 26 WL 3519294, at *5 (collecting cases with varying conclusions and 27 holding that the negligent misrepresentation claim in that case 28 sounded more in fraud and therefore was not barred by the 1 economic loss doctrine); Zakaria v. Gerber Prods., No. LA CV15- 2 00200, 2015 WL 3827654, at *11 (C.D. Cal. June 18, 2015) (in a 3 consumer class action, court held that negligent 4 misrepresentation was not barred by the economic loss doctrine); 5 Soil Retention Prods., Inc. v. Brentwood Indus., Inc., 521 F. 6 Supp. 3d 929, 956 (S.D. Cal. 2021) (negligent misrepresentation 7 claim was barred by the economic loss doctrine because the 8 alleged misrepresentations were those made in the course of 9 forming the contract). 10 It is possible that these cases may be reconcilable in 11 that some negligent misrepresentation claims may sound more in 12 fraud and others may sound more in negligence. In the present 13 case, the court cannot conclude at this stage of the proceeding 14 that plaintiff’s negligent misrepresentation claim is not of the 15 type that courts have allowed to go forward because it sounds in 16 fraud, for which economic loss is recoverable. Therefore, the 17 court will not dismiss the negligent misrepresentation claim. 18 The remainder of plaintiff’s claims do allow for 19 recovery for purely economic loss under these circumstances, and 20 therefore, they will not be dismissed. See NuCal Foods, Inc. v. 21 Quality Egg LLC, 918 F. Supp. 2d 1023, 1032-33 (E.D. Cal. 2013) 22 (holding that the economic loss doctrine did not bar fraud claims 23 based upon omissions or misrepresentations about a contaminated 24 product); Soil Retention Prods., 521 F. Supp. 3d at 957 25 (“[C]laims brought under California’s UCL are not subject to the 26 economic loss doctrine.”). 27 The complaint also sufficiently pleads “factual content 28 that allows the court to draw the reasonable inference that” 1 plaintiff’s economic loss was “the direct result of defendant[’s] 2 wrongful conduct.” Harmoni Int’l Spice, Inc. v. Hume, 914 F. 3d 3 648, 654 (9th Cir. 2019); (see compl. ¶ 9 (“[Plaintiff] 4 reasonably relied on these representations and warranties by 5 [d]efendant . . . in deciding to purchase the [p]roduct . . . 6 [and] he would not have purchased [it] . . . if the true facts 7 were known.”) 8 C. Class Claims 9 Defendant argues that the allegations in the complaint 10 that all the putative class members relied on the representations 11 and/or omissions in the same manner and suffered the same damages 12 are conclusory, and that the class claims should therefore be 13 dismissed. (Def.’s Mot. at 7-8.) The Ninth Circuit has opined 14 that “the pleadings alone will not resolve the question of class 15 certification and that some discovery will be warranted” and the 16 “more advisable practice” is for the court to “afford litigants 17 an opportunity to present evidence as to whether a class action 18 [is] maintainable.” Vinole v. Countrywide Home Loans, Inc., 571 19 F.3d 935, 942 (9th Cir. 2009). 20 Whether or not all the putative class members similarly 21 relied on and interpreted the representations made by defendant, 22 or suffered the same injuries are all premature questions that 23 defendant may instead raise at the class certification stage. 24 See Maestas v. Wal-Mart Stores, Inc., 2:16-cv-02597-KJM, 2018 WL 25 1518762, at *5 (E.D. Cal. Mar. 28, 2018) (holding the same); John 26 v. Mazo, 2:16-cv-00239, 2016 WL 4497755, at *2 (D. Nev. Aug. 25, 27 2016). Accordingly, plaintiff’s complaint will not be dismissed 28 based on this argument. 1 D. Rule 9(b) 2 Defendant also argues that plaintiff’s fraud-based 3 claims (1-2, 4-7, and 9-10) fail to meet the pleading standard 4 under Rule 9(b). Plaintiff must “state with particularity the 5 circumstances constituting fraud or mistake.” Fed. R. Civ. P. 6 9(b). Plaintiff must allege the “who, what, where, when, and how 7 of the misconduct charged” and “set forth what is false or 8 misleading about a statement, and why it is false.” See Vess v. 9 Ciba-Geigy Corp. USA, 317 F.3d 1097, 1106 (9th Cir. 2003) 10 (quotations and citations omitted). 11 The complaint meets this heightened standard under Rule 12 9(b) by providing detailed allegations. Plaintiff bought 13 defendant’s FogAway product in the summer of 2021. (Compl. ¶ 9.) 14 The complaint alleges the representations, or lack thereof, that 15 plaintiff saw on the advertisements and labeling of FogAway. 16 (Id.) Further, the complaint sufficiently pleads why and how 17 defendant’s representations about FogAway are false by alleging 18 the findings from the study done on FogAway and other studies 19 about PFAS generally. (Id. ¶¶ 2-5, 21-32.) The complaint 20 alleges that defendant omitted or mispresented the information 21 about PFAS so that consumers would purchase FogAway. (Id. ¶ 44.) 22 The complaint also alleges that plaintiff relied on the 23 representations, or lack thereof, and would have acted 24 differently if he knew about the existence of PFAS in FogAway. 25 (Id. ¶¶ 40, 45.) 26 “To comply with Rule 9(b), allegations of fraud must be 27 specific enough to give defendants notice of the particular 28 misconduct which is alleged to constitute the fraud charged so eee RI II EOI IIE NIE OEE eee

1 that they can defend against the charge and not just deny that 2 they have done anything wrong.” Swartz v. KPMG LLP, 476 F.3d 3 756, 764 (9th Cir. 2007) (citations and quotations omitted). 4 Here, the complaint gives defendant notice of the particular 5 alleged misconduct and summarizes plaintiff’s allegations based 6 on the Rule 9(b) standard. (See Compl. FI 39-45.) Accordingly, 7 | plaintiff’s fraud-based claims will not be dismissed based on a 8 failure to satisfy Rule 9(b). 9 IT IS THEREFORE ORDERED that defendant’s motion to 10 dismiss (Docket No. 7) be, and the same hereby is, GRANTED with 11 respect to plaintiff’s claims for money had and received and 12 negligent failure to warn (claims eight and fifteen) because he 13 concedes them, and DENIED in all other respects. 14 | Dated: August 4, 2022 . ak. AY / 15 WILLIAM B. SHUBB 16 UNITED STATES DISTRICT JUDGE

17 18 19 20 21 22 23 24 25 26 27 28 10